INTENSITY THERAPEUTICS, INC.

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

INTS

organization

SIC: 2836

SEC Insider

$263K

26 transactions

Summary

INTENSITY THERAPEUTICS, INC. (INTS) is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: —Sales: —7 insiders

Date	Insider	Type	Value
2026-03-26	BENDER LEWIS H(President and CEO)	A	$231K
2025-06-30	Wesolowski John M(Principal Accounting Officer)	A	$18K
2024-06-05	Wesolowski John M(Principal Accounting Officer)	M	$4K
2025-12-31	Talamo Joseph(Chief Financial Officer)	A	$4K
2025-06-30	Talamo Joseph(Chief Financial Officer)	A	$4K
2025-12-31	Wesolowski John M(Principal Accounting Officer)	A	$2K
2025-05-02	Talamo Joseph(Chief Financial Officer)	A	$0
2025-05-02	BENDER LEWIS H(President and CEO)	A	$0
2025-05-02	Wesolowski John M(Principal Accounting Officer)	A	$0
2025-05-02	Leahy Emer	A	$0
2025-05-02	GOLDBERG MARK A	A	$0
2025-05-02	Donovan Daniel	A	$0
2025-05-02	DUBIN THOMAS I H	A	$0
2025-05-02	Wesolowski John M(Principal Accounting Officer)	A	$0
2024-10-21	Talamo Joseph(Chief Financial Officer)	A	$0
2024-10-21	Wesolowski John M(Principal Accounting Officer)	A	$0
2024-06-05	Wesolowski John M(Principal Accounting Officer)	M	$0
2024-05-14	DUBIN THOMAS I H	A	$0
2024-03-06	BENDER LEWIS H(President and CEO)	A	$0
2024-03-06	BENDER LEWIS H(President and CEO)	A	$0

SEC filings: SEC EDGAR

Activity data: SEC EDGAR

INTENSITY THERAPEUTICS, INC. — Contributions, Lobbying & Contracts | Poliscope